Literature DB >> 19597473

Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.

H Ebi1, T Sato, N Sugito, Y Hosono, Y Yatabe, Y Matsuyama, T Yamaguchi, H Osada, M Suzuki, T Takahashi.   

Abstract

Small-cell lung cancer (SCLC) is a highly aggressive disease that exhibits rapid growth and genetic instability. We found earlier frequent overexpression of the miR-17-92 microRNA cluster, and showed that SCLC cells were addicted to continued expressions of miR-17-5p and miR-20a, major components of this microRNA cluster. In this study, we identified the frequent presence of constitutively phosphorylated H2AX (gamma-H2AX), which reflects continuing DNA damage, preferentially in SCLC. Knockdown of RB induced gamma-H2AX foci formation in non-small cell lung cancer (NSCLC) cells with wild-type RB, in association with growth inhibition and reactive oxygen species (ROS) generation, which was canceled by overexpression of miR-17-92. Conversely, induction of gamma-H2AX was observed in a miR-17-92-overexpressing SCLC cell line with miR-20a antisense oligonucleotides. These findings suggest that miR-17-92 overexpression may serve as a fine-tuning influence to counterbalance the generation of DNA damage in RB-inactivated SCLC cells, thus reducing excessive DNA damage to a tolerable level and consequently leading to genetic instability. Therefore, miR-17-92 may be an excellent therapeutic target candidate to elicit excessive DNA damage in combination with DNA-damaging chemotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597473     DOI: 10.1038/onc.2009.201

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

Review 1.  The microRNA-17-92 family of microRNA clusters in development and disease.

Authors:  Carla P Concepcion; Ciro Bonetti; Andrea Ventura
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

2.  The roles of microRNAs in tumorigenesis and angiogenesis.

Authors:  Weining Yang; Daniel Y Lee; Yaacov Ben-David
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-06-18

3.  Predicting microRNA-disease associations using bipartite local models and hubness-aware regression.

Authors:  Xing Chen; Jun-Yan Cheng; Jun Yin
Journal:  RNA Biol       Date:  2018-09-19       Impact factor: 4.652

4.  MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer.

Authors:  Roland Hubaux; Daiana D Becker-Santos; Katey S S Enfield; Stephen Lam; Wan L Lam; Victor D Martinez
Journal:  Metabolomics (Los Angel)       Date:  2012-03-21

Review 5.  Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2010-03       Impact factor: 3.828

6.  Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis.

Authors:  Jie Xiang; Ji Wu
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

7.  miR-17-92 cluster: ups and downs in cancer and aging.

Authors:  Johannes Grillari; Matthias Hackl; Regina Grillari-Voglauer
Journal:  Biogerontology       Date:  2010-05-01       Impact factor: 4.277

Review 8.  MicroRNA in lung cancer.

Authors:  P-Y Lin; S-L Yu; P-C Yang
Journal:  Br J Cancer       Date:  2010-09-21       Impact factor: 7.640

9.  MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.

Authors:  Lihua Lai; Yinjing Song; Yang Liu; Qingyun Chen; Quan Han; Weilin Chen; Ting Pan; Yuanyuan Zhang; Xuetao Cao; Qingqing Wang
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

10.  miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging.

Authors:  Matthias Hackl; Stefan Brunner; Klaus Fortschegger; Carina Schreiner; Lucia Micutkova; Christoph Mück; Gerhard T Laschober; Günter Lepperdinger; Natalie Sampson; Peter Berger; Dietmar Herndler-Brandstetter; Matthias Wieser; Harald Kühnel; Alois Strasser; Mark Rinnerthaler; Michael Breitenbach; Michael Mildner; Leopold Eckhart; Erwin Tschachler; Andrea Trost; Johann W Bauer; Christine Papak; Zlatko Trajanoski; Marcel Scheideler; Regina Grillari-Voglauer; Beatrix Grubeck-Loebenstein; Pidder Jansen-Dürr; Johannes Grillari
Journal:  Aging Cell       Date:  2010-01-18       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.